EIKONOKLASTES THERAPEUTICS, INC. — Form D
EIKONOKLASTES THERAPEUTICS, INC. of CINCINNATI, OH, a company, filed a Form D exempt-offering notice with the SEC on 2022-01-13. The offering totals $7.0M, of which $2.8M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2022-01-13
- Form: D
- Accession: 0001805698-22-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $7.0M
- Amount sold: $2.8M
- Remaining: $4.2M
- Investors: 1
- Date of first sale: 2021-12-31
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-429236
Issuer
- Name: EIKONOKLASTES THERAPEUTICS, INC.
- CIK: 0001805698
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 2356 PARK AVENUE, CINCINNATI, OH, 45206
- Phone: (513) 549-6484
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Samuel Lee | Director | San Juan, PR |
| Samuel Lee | Executive Officer | San Juan, PR |
| Samuel Lee | Promoter | San Juan, PR |
| ROBERT JOHNSON | Director | East Lansing, MI |
| Neel Patel | Director | Walnut Creek, CA |
| Thomas Finn | Director | Cincinnati, OH |
| Joseph Nolan | Director | Lake Bluff, IL |
| Bruce Halpryn | Director | Cincinnati, OH |
| Bruce Halpryn | Executive Officer | Cincinnati, OH |
| Bruce Halpryn | Promoter | Cincinnati, OH |
| Kenneth Morand | Director | Cincinnati, OH |
| Meyer Frucher | Director | Cincinnati, OH |
Other filings by this issuer (5)
More